30.11.2017 12:13:10
|
Sinovac: Nasdaq Panel Extends Stay Of Suspension In Trading - Quick Facts
(RTTNews) - Sinovac Biotech Ltd. (SVA) announced that the Nasdaq Hearings Panel has granted the company's request to extend the stay of suspension in trading of the company's common shares pending a hearing on January 11, 2018 and issuance of a final Panel decision.
On November 8, 2017, the company appealed to the Panel the Nasdaq Staff's delisting determination dated November 1, 2017.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sinovac Biotech LtdShsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Sinovac Biotech LtdShsmehr Analysen
Aktien in diesem Artikel
Sinovac Biotech LtdShs | 6,47 | -0,31% |
|